24 related articles for article (PubMed ID: 31145904)
1. Layilin augments integrin activation to promote antitumor immunity.
Mahuron KM; Moreau JM; Glasgow JE; Boda DP; Pauli ML; Gouirand V; Panjabi L; Grewal R; Luber JM; Mathur AN; Feldman RM; Shifrut E; Mehta P; Lowe MM; Alvarado MD; Marson A; Singer M; Wells J; Jupp R; Daud AI; Rosenblum MD
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32539073
[TBL] [Abstract][Full Text] [Related]
2. Specifically Sized Hyaluronan (35 kDa) Prevents Ethanol-Induced Disruption of Epithelial Tight Junctions Through a layilin-Dependent Mechanism in Caco-2 Cells.
Bellos DA; Sharma D; McMullen MR; Wat J; Saikia P; de la Motte CA; Nagy LE
Alcohol Clin Exp Res; 2019 Sep; 43(9):1848-1858. PubMed ID: 31237689
[TBL] [Abstract][Full Text] [Related]
3. Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs.
Wienke J; Brouwers L; van der Burg LM; Mokry M; Scholman RC; Nikkels PG; van Rijn BB; van Wijk F
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32809975
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
[TBL] [Abstract][Full Text] [Related]
5. ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Cao L; Zhu L; Cheng L
Biomed Res Int; 2022; 2022():5357114. PubMed ID: 36398067
[TBL] [Abstract][Full Text] [Related]
6. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
PeerJ; 2022; 10():e12991. PubMed ID: 35223210
[TBL] [Abstract][Full Text] [Related]
7. Psychological Stress Up-Regulates CD147 Expression Through Beta-Arrestin1/ERK to Promote Proliferation and Invasiveness of Glioma Cells.
Wang P; Wang Z; Yan Y; Xiao L; Tian W; Qu M; Meng A; Sun F; Li G; Dong J
Front Oncol; 2020; 10():571181. PubMed ID: 33178600
[TBL] [Abstract][Full Text] [Related]
8. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
[TBL] [Abstract][Full Text] [Related]
9. Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling.
Kaji T; Arito M; Tsutiya A; Sase T; Onodera H; Sato T; Omoteyama K; Sato M; Suematsu N; Kurokawa MS; Tanaka Y; Kato T
Brain Res; 2019 Sep; 1719():140-147. PubMed ID: 31145904
[TBL] [Abstract][Full Text] [Related]
10. Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14.
Chen W; Xia T; Wang D; Huang B; Zhao P; Wang J; Qu X; Li X
Oncotarget; 2016 Sep; 7(38):62425-62438. PubMed ID: 27613828
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.
Song L; Liu L; Wu Z; Lin C; Dai T; Yu C; Wang X; Wu J; Li M; Li J
J Pathol; 2012 Feb; 226(3):534-43. PubMed ID: 21960069
[TBL] [Abstract][Full Text] [Related]
12. IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.
Zhang JF; Wang P; Yan YJ; Li Y; Guan MW; Yu JJ; Wang XD
Oncol Rep; 2017 Oct; 38(4):2033-2042. PubMed ID: 28849217
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
